| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.088 | 0.03 |